Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of king cobra toxin protease inhibitor and its derivatives

A protease inhibitor, snake venom technology, applied in the field of biomedicine

Inactive Publication Date: 2010-06-09
KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

To date, most Kunitz-type protease inhibitors act on either trypsin or chymotrypsin, and few Kunitz-type protease inhibitors act on both trypsin and chymotrypsin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of king cobra toxin protease inhibitor and its derivatives
  • Application of king cobra toxin protease inhibitor and its derivatives
  • Application of king cobra toxin protease inhibitor and its derivatives

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0104] Embodiment 1: Separation, purification and activity determination of king cobra venom protease inhibitor

[0105] 1. Separation and purification

[0106] During the separation and purification process, the inhibitory activity against trypsin and chymotrypsin was detected to track:

[0107] The first step, molecular sieve Sephadex G-50 gel filtration: King cobra crude venom 0.5g is dissolved in 3ml phosphate buffer (Na 2 HPO 4 -NaH 2 PO 4 , pH 5.8, containing 0.1M NaCl), through Sephadex G-50 gel. G-50IV peak has dual inhibitory activity on trypsin and chymotrypsin, attached figure 1 arrow peak.

[0108] In the second step, the G-50IV peak was further separated and purified by trypsin affinity chromatography. Has dual inhibitory activity against trypsin and chymotrypsin in the hydrochloric acid elution peak, attached figure 2 arrow peak.

[0109] The third step, HPLC-RP-C 18 Purification of Trypsin Affinity Chromatography Eluted Peaks by Hydrophobic Chromatogr...

Embodiment 2

[0114] Embodiment 2: Structural determination and molecular cloning of king cobra venom protease inhibitor

[0115] 1. Structure determination:

[0116] Determination of N-terminal partial amino acid sequence

[0117] The purified main peak protein was subjected to Edman degradation method on an automatic protein sequencer (476A type, product of Applied Biosystems, USA), and the sequence of the N-terminal 20 amino acid residues of the main peak protein was determined.

[0118] Matrix-Assisted Laser Desorption Time-of-Flight Mass Spectrometry (MALDI-TOF-MS) Detection

[0119] The purified main peak protein was determined by MALDI-TOF-MS (Bunker) to determine its precise molecular weight.

[0120] 2. Molecular cloning:

[0121] Construction of cDNA Library of King Cobra Venom Gland

[0122] 1) Extraction of total RNA from king cobra venom glands: three days after taking venom from live king cobras, put them into liquid nitrogen for 4 hours and then peel off the venom gland t...

Embodiment 3

[0127] Embodiment 3: the prokaryotic expression of recombinant king cobra venom protease inhibitor

[0128] Expression of recombinant protein in Escherichia coli

[0129] 1. The cloned king cobra venom trypsin / chymotrypsin dual-functional inhibitor (OH-TCI) was amplified by PCR, and the 5'-terminal primer used corresponds to the N-end of the mature polypeptide, and the 3'-primer corresponds to the mature polypeptide The C-terminus of the polypeptide contains a restriction endonuclease Hind III cleavage site and protected nucleotides. PCR amplification was performed using high-fidelity DNA polymerase Pyrobest, a product of Treasure Bioengineering (Dalian) Co., Ltd. After the product was recovered, it was digested with restriction endonuclease Hind III, and then ligated with the expression vector (pMAL-p2X) cut with restriction endonuclease Xmn I and Hind III for blunt-sticky ends, and transformed into E. coli DH5α in cells. The expression vector pMAL-p2X was purchased from N...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a king cobra viper venom inhibitor and a relative derivative. Compared with other natural low-molecular-weight prolease inhibitor, the inventive inhibitor has simple structure, high gene expression yield, and special activity. The preparation method of the king cobra viper venom inhibitor can be prepared by separating and purifying crude venom or prepared by gene engineering. The invention further provides the application of the king cobra viper venom inhibitor and relative derivative, which has double inhibition activity of parenzyme and chymotrypsin, in same magnitude order as the inhibition constant on two proleases, and the inhibition activity with sodium channel.

Description

technical field [0001] The invention relates to the application of a king cobra venom protease inhibitor and its derivatives, belonging to the field of biomedicine. Background technique [0002] Protease inhibitors are proteins or small peptides that widely exist in animals, plants and microorganisms and can inhibit the hydrolytic activity of proteases. Protease inhibitors can bind to the active site and / or allosteric site of protease, thereby inhibiting the catalytic activity of the enzyme and / or the binding of the protease to the natural substrate, preventing the zymogen from being converted into an active enzyme, and thus regulating protease activity and plays an important role in substance metabolism. It also plays a key regulatory role in a series of physiological and pathological processes. Protease inhibitors have the prospect of being developed into new drugs that are beneficial to human health. They have shown great promise in the treatment of AIDS, pancreatitis, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/57A61P7/04C07K14/81A61P31/18A61P1/18
Inventor 李文辉张云何英英刘树柏
Owner KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com